STEFANO FERRERO BOGETTO VIA ORTI MILANO - unimi.it · FO R M A T O EU R O P EO P E R I L C U R RI C...

Pagina 1 - Curriculum vitae di FERRERO BOGETTO Stefano

F O R M A T O E U R O P E O

P E R I L C U R R I C U L U M

V I T A E

INFORMAZIONI PERSONALI

Nome STEFANO FERRERO BOGETTO

Indirizzo VIA ORTI 16, 20122 MILANO

Telefono +39 02 54 10 17 50 – cellulare 338 71 22 450

Fax + 39 02 503 23168

E-mail [email protected]

Nazionalità Italiana

Data di nascita 2 GENNAIO 1963

ISTRUZIONE E FORMAZIONE

7/06/2017 Abilitazione Scientifica Nazionale a Professore di I Fascia settore concorsuale 06/A4 Anatomia Patologica.

1/12/2016 Direttore f.f. UOC Anatomia Patologica Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

1/11/2010 Presa di servizio in qualifica di Professore Associato in Anatomia Patologica Universita’ degli Studi di Milano

11/11/1995 al 31/10/2010 Ricercatore confermato in Anatomia Patologica Università degli Studi di Milano

11/11/1992 Nominato Ricercatore in Anatomia Patologica Università degli Studi di Milano

1992 Vincitore concorso Ricercatore Universitario Gruppo F06- Anatomia Patologica

1991 Specializzazione in Anatomia Patologica

Università degli Studi di Brescia

Titolo: Valutazione delle regioni organizzatrici del nucleolo nei tumori mucinosi dell’ovaio

70/70 e lode

1987 Laurea in Medicina e Chirurgia

Università degli Studi di Milano


Titolo: Adenoma pleomorfo della ghiandola parotide: valutazioni immunoistochimiche

Relatore: Prof. L. Mosca

Votazione: 110/110

1981 Diploma di maturità classica

Liceo ginnasio statale “C. Beccaria” di Milano

PRIMA LINGUA ITALIANO

ALTRE LINGUE

INGLESE

• Capacità di lettura eccellente

• Capacità di scrittura eccellente

• Capacità di espressione orale

eccellente

ATTIVITÀ DIDATTICA

al 2006 ad oggi

Titolare dell’insegnamento di Anatomia Patologica per il corso di Laurea in Odontoiatria e Protesi Dentaria. Nell’ambito del corso di laurea in Odontoiatria e Protesi dentaria ai crediti formativi assegnati nel numero di 9 ha corrisposto: 20 ore di didattica per il tirocinio II anno per il Polo Centrale 18 ore di didattica per la Diagnostica di Laboratorio 20 ore di didattica per il tirocinio II anno per il Polo S. Paolo 54 ore di didattica per il Corso Integrato di Fisiopatologia generale ed Anatomia Patologica. 12 ore di didattica per il corso di Diagnostica strumentale e per immagini. Totale ore di didattica annuale erogate per il CLOP: 124. Partecipa regolarmente e con continuità con qualifica di Presidente o Docente di Commissione a tutte le sedute di esami nei corsi sopraelencati per il CLOPD. Ai sopraelencati impegni didattici gli e’ attribuito con decreto Rettorale: 30 ore di insegnamento per la Semeiotica e Sistematica II Polo Centrale D per il CDL. In Medicina e Chirurgia 33 ore di insegnamento per il Corso di Anatomia Patologica Polo Centrale D per CDL. In Medicina e Chirurgia. Partecipa all’attività didattica specie in forma tutoriale per il Corso di Anatomia Patologica svolto presso il polo S. Paolo, Università degli Studi di Milano


Dal 1994 ad oggi

Docente II Scuola di Specializzazione in Anatomia Patologica, Università degli Studi di Milano Dal 1991 ad oggi

Svolge attività didattica formale e tutoriale agli studenti del corso di Laurea in Medicina e Chirurgia - Polo Centrale Policlinico di Milano per il corso di Anatomia Patologica (Titolari del corso: 1990-1991: Prof. L. Mosca, 1992-2001: Prof. R. Buffa, 2002-2008: Prof. G. Coggi). Risulta presente in qualifica di Relatore o Correlatore alla presentazione di diverse tesi di Laurea in Medicina e Chirurgia. Ai suddetti impegni didattici si e’ aggiunta in forma continuativa partecipazione alle commissioni esaminatrici per il corso di Laurea in Medicina e Chirurgia e per le Scuole di Specializzazione.

ATTIVITÀ DI RICERCA IMPACT FACTOR: 577,911 H.I. Scopus 26; Scholar 33

PRINCIPALI LINEE DI RICERCA

Studio degli Ag.NOR (Regioni Organizzatici del Nucleolo) nei tumori solidi umani. Aspetti differenziativi neuroendocrini nelle neoplasie solide umane con particolare riguardo al distretto gastroenterico e polmonare e loro significato clinico-prognostico. Espressione di protooncogeni e geni oncosoppressori mediante tecniche immunoistochimiche e molecolari nei tumori solidi umani. Studio mediante sperimentazione animale delle cellule staminali nel danno tissutale con particolare riguardo alla riparazione del miocardio. Studio dei meccanismi regolatori dell’infiammazione (specie sistema bradichinergico) nelle malattie infiammatorie croniche idiopatiche intestinali. Studio del proteoma nel carcinoma a cellule renali. Studio del Recettore della proteina C endoteliale (EPCR) nelle patologie infiammatorie


intestinali e nei tumori solidi umani. Studio degli inibitori di pompa protonica (V-ATPasi) e delle Pentraxine nei tumori umani gliali.

PRINCIPALI COLLABORAZIONI SCIENTIFICHE

Dipartimento di Medicina Interna, Servizio di Gastroenterologia Università degli Studi di Milano e Sol Sherry Thrombosis Research Center, Temple University, Philadelphia, USA. Biochimica clinica e biologia molecolare clinica. Università degli Studi di Milano-Bicocca. Facoltà di Medicina e chirurgia. Istituto di Clinica Medica Generale e Terapia medica, Centro di Fisiologia Clinica e Ipertensione, Università di Milano. Istituto di Scienze Endocrine, Ospedale Maggiore IRCCS di Milano e Università di Milano. Tumor microenvironment and metastasis program, The Winstar Insitute, Philadelphia, USA

PROGRAMMI DI RICERCA SCIENTIFICA FINANZIATI DAL MIUR


Anno 2000

First Finanziamento: 3.410,87 Euro

Anno 2001

COFIN prot. 2001058539-006 Proteoma nel carcinoma a cellule renali (RCC): il ruolo della preparazione tissutale con particolare riferimento alla micro dissezione laser. Coordinatore Scientifico del Programma: Paolo Mocarelli. Responsabile Scientifico dell’Unità di ricerca: Stefano Ferrero Bogetto. Finanziamento totale: 19.109 Euro First Finanziamento: 1.333,26 Euro

Anno 2002


Anno 2003


Anno 2004

PRIN prot. 2004061903_003: Studio della relazione genotipo/fenotipo del carcinoma renale a cellule chiare mediante tecnologie genomiche innovative quali i DNA microarray e la real time PCR. Coordinatore Scientifico del Programma: Paolo Mocarelli. Responsabile Scientifico dell’Unità di ricerca: Stefano Ferrero Bogetto Finanziamento totale: 77.300 Euro First Finanziamento: 3.666,91

Anno 2005

First. Titolo: Valutazione dell’espressione del gene SEL-1 nei carcinomi polmonari non a piccole cellule (NSCLC). Finanziamento: 4.714,43 Euro

Anno 2006 PRIN prot. 2006069373_003: Identificazione di profili di espressione proteica e di instabilità cromosomica nel RCC mediante l’utilizzo di tecnologie innovative quali Tissue Microarray (TMA) e Methylation Array. Coordinatore scientifico del programma : Fulvio Magni. Responsabile Scientifico dell’Unità di ricerca: Stefano Ferrero Bogetto


Finanziamento totale: 37.200 Euro First. Titolo: Valutazione dell’espressione del gene SEL-1 nella sequenza adenoma-carcinoma colo-rettale. Finanziamento: 4.647,60 Euro

Anno 2007 First. Titolo: Espressione del recettore della proteina C endoteliale nel carcinoma mammario. Finanziamento: 5.072,88 Euro

ATTIVITÀ ASSISTENZIALE

Dal 2004 ad oggi Dirigente Medico di I livello

Unità Operativa di Anatomia Patologica dell’ Azienda Ospedaliera S. Paolo di Milano

II Cattedra di Anatomia Patologica (Dir. Prof. G. Coggi)

Via Antonio di Rudinì 8 – 20143 Milano

Principali mansioni e responsabilità

Incaricato di supervisionare la casistica istologica e/o citologica dell’Unità Operativa Particolari campi di competenza diagnostica: 1) citologia per agoaspirazione polmonare. 2) patologia neoplastica polmonare 3) patologia endocrina 4) patologia gastroenterica (specialmente in riferimento alle malattie

infiammatorie croniche idiopatiche intestinali). 5) patologia neoplastica del sistema nervoso centrale.

Dal 2000 ad oggi Dirigente Medico di I livello

Unità Operativa di Anatomia Patologica dell’ Azienda Ospedaliera S. Paolo di Milano


II Cattedra di Anatomia Patologica (Dir. Prof. G. Coggi)

Via Antonio di Rudinì 8 – 20143 Milano


Svolge attività diagnostica autoptica, citologica ed istologica dei campioni provenienti dall’azienda Ospedaliera S. Paolo e dall’Ospedale Maggiore IRCCS di Milano

Dal 1991 al 1999 Dirigente Medico di I livello III Cattedra di Anatomia Patologica dell’Università degli Studi di Milano II Servizio di Anatomia Patologica dell’Ospedale Maggiore di Milano (Responsabili: Prof. L. Mosca e successivamente Prof. R. Buffa)

Via della Commenda 19 – 20122 Milano


Svolge in forma continuativa attività assistenziale autoptica, istologica e citologica. Numero stimato di casi siglati/validati esami autoptici: 200 esami citologici: 15.000 esami istologici:75.000 esami istologici intraoperatori: 2000


ALLEGATI

LAVORI A STAMPA PRESENTI IN ARCHIVIO PUB MED

TOTALE IMPACT FACTOR: 577,911

H.I. SCOPUS : 26

H.I. SCHOLAR : 33

1) Barbareschi M, Ferrero S, Ottaviani F. Alveolar soft part sarcoma of the nasal cavity. Pathologica 1988. 2) Barbareschi M, Ferrero S, Frigo B, Mariscotti C, Mosca L. Bronchial carcinoid with S-100 positive sustentacular cells. Tumori 1988 .I.F: 0.739 3) Giordanengo F, Beretta L, Galimberti M, Ferrero S. A rare case of aneurysm of the superficial femoral artery with dysplasic etiology] Minerva Chir 1989. 4) Mauri FA, Barbareschi M, Scampini S, Ferrero S, Perrone G. Nucleolar organizer regions in mucinous tumours of the ovary. Histopathology 1990. I.F: 2.608 5) Barbareschi M, Ferrero S, Aldovini D, Leonardi E, Colombetti C, Carboni N, Mariscotti C. Inflammatory pseudotumour of the lung. Immunohistochemical analy on four new cases. Histol Histopathol 1990. I.F: 2.023 6) Barbareschi M, Mariscotti C, Ferrero S, Pignatiello U. Intranodal haemorrhagic spindle cell tumour: a benign Kaposi-like nodal tumour. Histopathology 1990. I.F: 2.608 7) Mauri FA, Muscara M, Ferrero S, Barbareschi M, Scampini S, Perrone G. AgNOR counts in endometrial and endocervical carcinomas. Pathologica 1990. 8) Mauri FA, Scampini S, Aldovini D, Ferrero S, Barbareschi M, Dalla Palma P. AgNOR distribution in serous tumours of the ovary. Pathologica 1990. 9) Mauri FA, Ferrero S, Barbareschi M, Scampini S, Muscara M, Motta M, Pignataro L. AgNOR distribution in normal and dysplastic 8 fan8sa mucosa and in 8 fan8sa epidermoid carcinomas. Pathologica 1990.


10) Barbareschi M, Colombetti V, Ferrero S, Yousem SA, Singh G. Sclerosing haemangioma of the lung. Histol Histopathol 1992. I.F: 2.023 11) Pelagi M, Zanini A, Gasparri A, Ermellino L, Ferrero S, Siccardi AG, Buffa R. Immunodetection of secretogranin II in animal and human tissues by new monoclonal antibodies. Regul Pept 1991. I.F: 2.272 12) Bianca A, Carboni N, Di Carlo V, Falleni M, Ferrero S, Liverani C, Staudacher C, Turra G, Vergani D, Zerbi A. Pancreatic malignant melanoma with occult primary lesion. A case report. Pathologica 1992. 13) Ferrero S, Buffa R, Pruneri G, Siccardi AG, Pelagi M, Lee AK, Coggi G, Bosari S. The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas. Virchows Arch 1995. I.F: 2.224 14) Pruneri G, Pignataro L, Fracchiolla NS, Ferrero S, Capaccio P, Carboni N, Ottaviani A, Maiolo AT, Neri A, Buffa R. p53 protein expression in laryngeal squamous cell carcinomas bearing wild-type and mutated p53 gene. Histopathology 1996. I.F:2.608 15) Coggi G, Bosari S, Roncalli M, Graziani D, Bossi P, Viale G, Buffa R, Ferrero S, Piazza M, Blandamura S, Segalin A, Bonavina L, Peracchia A. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer 1997. I.F: 4.800 16) Granelli P, Fichera G, Zennaro F, Siardi C, De Ruberto F, Fregoni F, Appierto V, Buffa R, Ferrero S, Biunno I. Expression of the epidermal growth factor receptor gene in human intestinal metaplasia: a preliminary report. Scand J Gastroenterol 1997. I.F: 1.790 17) Dasdia T, Bazzaco S, Bottero L, Buffa R, Ferrero S, Campanelli G, Dolfini E. Organ culture in 3-dimensional matrix: in vitro model for evaluating biological compliance of synthetic meshes for abdominal wall repair. J Biomed Mater Res 1998. I.F: 3.652 18) Bonavina L, Cioffi U, Lattuada E, Ferrero S, Buffa R.: Benign Pancreatic schwannoma. Dig. Surg 1997. I.F:1.081


19) De Vecchi E, Lubatti L, Beretta C, Ferrero S, Rinaldi P, Galli- Kienle M, Trazzi R, Paroni R.Protection from renal ischemia-reperfusion injury by the 2-methylaminochroman U83836E. Kidney Int. 1998. I.F: 4.927 20) Bonavina L, Fociani P, Asnaghi D, Ferrero S. Synovial sarcoma of the esophagus simulating achalasia.

Dis Esophagus 1998. I.F: 0.936

21) Cioffi U, De Simone M, Nosotti M, Bellaviti N, Naimzada AN, Ferrero S, Santambrogio L Hyaline vascular Castleman’s disease of the mediastinum. Int Surg 1999. I.F. :0.432 22) Cioffi U, De Simone M, Pavoni G, Poggi L, Pisani D, Ferrero S, Santambrogio L. Pulmonary capillary hemangiomatosis in an asymptomatic elderly patient. Int Surg 1999. I.F : 0.432 23) Bonavina L, Ceriani C, Carazzone A, Segalin A, Ferrero S, Peracchia Endoscopic laser ablation of nondysplastic Barrett’s epithelium: is it worthwhile? J Gastrointest Surg 1999. I.F : 2.290 24) Bonavina L, Ferrero S, Midolo V, Buffa R, Cesana B, Peracchia A. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction. J Gastrointest Surg 1999. I.F: 2.290 25) Doglioni C, Mauri FA, Ferrero S, Russo AG, Midolo de Luca V, Caffo O, Galligioni E, Dalla Palma P, Barbareschi M. Heterogeneous expression of cyclin D3 in breast carcinoma:absence of prognostic significance in a series of 92 cases with long follow-up Pathologica 1999. 26) Mauri F.A., Maissonneuve P, Caffo O, Veronese S, Aldovini D, Ferrero S, Cozzaglio F, Dalla Palma P, Galligioni E, Barbareschi M: Prognostic value of estrogen receptor status can be improved by combined evaluation of p53, Bcl-2 and PgR expression: an immunohistochemical study on breast carcinoma with long-term follow-up. Int. J. Oncol 1999. I.F: 2.681 27) Miadonna A, Gibelli S, Tedeschi A, Bonelli N, Ferrero S. Favourable outcome of a case of pulmonary Langerhans’ cell histiocytosis. Monaldi Arch Chest Dis 2000. 28) Avesani EC, Cioffi U, De Simone M, Botti F, Carrara A, Ferrero S. Synchronous isolated splenic metastasis from colon carcinoma. Am J Clin Oncol 2001. I.F: 1.615


29) Doglioni C, Barbareschi M, Ferrero S, Buffa R. Prognostic markers in malignant 11 fan11satel. Adv Clin Path 2000. 30) Airaghi L, Ciceri L, Giannini S, Ferrero S, Meroni PL, Tedeschi A. Idiopathic pulmonary hemosiderosis in an adult. Favourable response to azathioprine. Monaldi Arch Chest Dis 2001. 31) Santambrogio L, Cioffi U, De Simone M, Rosso L, Ferrero S, Giunta A. Video-assisted sleeve lobectomy for mucoepidermoid carcinoma of the left lower lobar bronchus: a case report. Chest 2002. I.F: 4.008 32) Castoldi L, De Rai P, Marini A, Ferrero S, De Luca VM, Tiberio G. Neurofibromatosis-1 and ampullary gangliocytic paraganglioma causing biliary and pancreatic obstruction. Int J Pancreatol 2001. I.F: 1.542 33) Ciulla MM, Paliotti R, Ferrero S, Vandone P, Magrini F, Zanchetti A. Assessment of carotid plaque composition in hypertensive patients by ultrasonic tissue characterization: a validation study. J Hypertens 2002. I.F: 5.218 34) Devani M, Cugno M, Vecchi M, Ferrero S, Di Berardino F, Avesani EC, de Franchis R, Colman RW. Kallikrein-kinin system activation in Crohn’s disease: differences in intestinal and systemic markers. Am J Gastroenterol 2002. I.F: 5.116 35) Torgano G, Mandelli C, Massaro P, Abbiati C, Ponzetto A, Bertinieri G, Ferrero S, Terruzzi E, de Franchis R. Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori. Br J Haematol 2002. I.F:4.080 36) Ferrero S, Cattaneo L, Peri A, Braidotti P, Cioffi U, Scaramellini G, Ciulla MM, De Simone M, Arizzi C, Pignataro L. Poorly differentiated carcinoma arising from adenolymphoma of the parotid gland. BMC Surg 2003. I.F: 1.333 37) Dolfini E, Elli L, Ferrero S, Braidotti P, Roncoroni L, Dasdia T, Falini ML, Forlani F, Bardella MT. Bread wheat gliadin cytotoxicity: a new three-dimensional cell model. Scand J Clin Lab Invest 2003. I.F: 1.253 38) Ciulla MM, Lazzari L, Pacchiana R, Esposito A, Bosari S, Ferrero S, Gianelli U, Paliotti R, Busca G, Giorgetti A, Magrini F, Rebulla P. Homing of peripherally injected bone marrow cells in rat after experimental myocardial injury. Haematologica 2003. I.F: 4.192


39) Cioffi U, De Simone M, Santambrogio R, Fortis D, Ferrero S, Ciulla MM, Montorsi M Laparoscopic enucleation of solitary true pancreatic cyst in an adult. J Gastrointest Surg 2003. I.F: 2.290 40) Ciulla MM, Paliotti R, Ferrero S, Braidotti P, Esposito A, Gianelli U, Busca G, Cioffi U, Bulfamante G, Magrini F. Left ventricular 12 fan12satel after experimental myocardial cryoinjury in rats. J Surg Res 2004. I.F: 1.956 41) Ciulla MM, Ferrero S, Lazzari L, Pacchiana R, Paliotti R, Gianelli U, Busca G, Esposito A, Bosari S, Magrini F, Rebulla P. The translocation of marrow MNCs after experimental myocardial cryoinjury is proportional to the 12 fan12sat area. Transfusion 2004. I.F: 3.160 42) Faioni EM, Ferrero S, Fontana G, Gianelli U, Ciulla MM, Vecchi M, Saibeni S, Biguzzi E, Cordani N, Franchi F, Bosari S, Cattaneo M. Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit Care Med 2004. I.F: 5.077 43) Bonavina L, Incarbone R, Midolo V, Bona D, Ferrero S, Dall’Asta C. Prognostic 12 fan12satell of lymphatic micrometastasis of esophageal adenocarcinoma. Chir Ital 2004. 44) Sarto C, Valsecchi C, Magni F, Tremolada L, Arizzi C, Cordani N, Casellato S, Doro G, Favini P, Perego RA, Raimondo F, Ferrero S, Mocarelli P, Galli-Kienle M. Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics 2004. I.F: 6.088 45) Ambrosi B, Dall’Asta C, Cannavo S, Libe R, Vigo T, Epaminonda P, Chiodini I, Ferrero S, Trimarchi F, Arosio M, Beck-Peccoz P. Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing’s disease. Eur J Endocrinol 2004. I.F: 2.962 46) Granelli P, Cattaneo M, Ferrero S, Bottiglieri L, Bosari S, Fichera G, Biunno I. SEL1L and squamous cell carcinoma of the esophagus. Clin Cancer Res 2004. I.F:5.715 47) De Simone M, Cioffi U, Contessini-Avesani E, Oreggia B, Paliotti R, Pierini A, Bolla G, Oggiano E, Ferrero S, Magrini F, Ciulla MM. Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery. BMC Gastroenterol 2004 I.F: 1.455


48) Lania AG, Mantovani G, Ferrero S, Pellegrini C, Bondioni S, Peverelli E, Braidotti P, Locatelli M, Zavanone ML, Ferrante E, Bosari S, Beck-Peccoz P, Spada A. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Res 2004. I.F: 7.616 49) Magni F, Sarto C, Valsecchi C, Casellato S, Ferrero S, Bosari S, Di Fonzo A, Perego R., Corizzato M, Doro G, Galbusera C, Rocco F, Mocarelli P, Galli Kienle M. Expanding the proteome two-dimensional gel electrophoresis reference map of human renal cortex by peptide mass fingerprinting Proteomics 2005 .I.F: 6.088 50) Devani M, Vecchi M, Ferrero S, Contessini Avesani E, Arizzi C, Chao L, Colman RW, Cugno M. Kallikrein-kinin system in inflammatory bowel diseases: intestinal involvement and correlation with the degree of tissue inflammation. Dig Liver Disease 2005. I.F: 1.818 51) Dolfini E, Elli L, Roncoroni L, Costa B, Colleoni M.P., Lorusso V, Ramponi S, Braidotti P, Ferrero S, Falini M, Bardella M.T: Demaging effects of gliadin on a three-dimensional cell culture model. World J Gastroenterol 2005. I.F: 3.318 52) Corbetta S, Vicentini L, Ferrero S, Lania A, Mantovani G, Cordella D, Beck-Peccoz P, Spada A: Activity and function of the NF-KB pathway in human parathyroid tumors. Endocrine-related Cancer 2005. I.F: 4.905 53) Perego R, Bianchi C, Corizzato M, Eroini B, Torsello B, Valsecchi C, Di Fonzo A, Cordani N, Favini P, Ferrero S, Pitto M, Sarto C, Magni F, Rocco F, Mocarelli P: Primary cell cultures arising from normal kidney and renal cell carcinoma retain the 13 fan13s profile of corresponding tissues. J Proteome Research 2005. I:F: 6.901 54) Mantovani G, Bondioni S, Ferrero S, Gamba B, Ferrante E, Peverelli E, Corbetta S, Locatelli M, Rampini P, Beck-Peccoz P, Spada A, Lania A: Effect of cyclic-AMP/PKA pathway on markers of cell proliferation in non-funtioning pituitary adenomas. J Clin Endocrinol Metabol 2005. I.F: 5.799

55) Villa F, Rumi Maria, Signorelli C, Saibeni S, Del Ninno E, Ferrero S, de Franchis R, Vecchi M: Onset of inflammatory bowel diseases during combined alpha-interferon and ribavirin therapy for chronic hepatitis C: report of two cases. Eur J Gastroenterol Hepatol 2005. I.F: 1.690 56) Cioffi U, De Simone M, Ferrero S, Ciulla M, Lemos A, Contessini Avesani E: Synchronous adenocarcinoma and carcinoid tumor of the terminal ileum in a Crohn’s disease patient.


BMC Cancer 2005. I.F: 1.992 57) Biunno I, Cattaneo M, Orlandi R, Canton C, Biagiotti L, Malferrari G, Ferrero S, Barberis M, Pupa S, Scarpa A, Menard S: SEL1L a multifaceted protein playing a role in tumor progression. Review. J Cell Physiol.2006. I.F: 4.362 58) Ferrero S, Falleni M, Cattaneo M, Malferrari G, Canton C, Biagiotti L, Maggioni M, Nosotti M, Coggi G, Bosari S, Biunno I: Sel1L expression in non –small cell lung cancer. Human Pathol 2006. I.F: 2.550 59) Ambrosini-Spaltro, Vaira v, Braidotti P, Rovati M, Ferrero S, Bosari S: Carcinosarcoma of the colon: report of a case with morphological, ultrastructural and molecular analysis. BMC Cancer 2006. I.F: 1.992 60) Ciulla M, Ferrero S, Montelatici E, Gianelli U, Braidotti P, Calderoni S, Paliotti R, Annoni G, De Camilli E, Busca G, Magrini F, Bosari S, Lazzari L, Rebulla P: Assessment of selective homing and contribution to vassel formation of cryopreserved peripherally injected bone marrow mononuclear cells following experimental myocardial demage Current Drug Targets 2006. I.F: 4.398 61) Bongiovanni M, Ranieri R, Ferrero S, Casanova F, d’Arminio Monforte A: Crohn’s disease onset in a HIV/HCV co-infected woman taking pegylated interferon plus ribavirin. AIDS 2006. I.F: 5.835 62) Ciulla M, Ferrero S, Gianelli U, Paliotti R, Magrini F, Braidotti P:Direct visualization of neo-vessel formation following peripheral injection of bone marrow derived CD34+ cells in experimental myocardial damage. Micron 2007. I.F: 1.289 63) Verga U, Ferrero S, Vicentini L, Brambilla T, Cirello V, Muzza M, Beck-Peccoz P, Fugazzola L: Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Endocrine-related cancer 2007. I.F: 4.905 64) Mantovani G, Bondioni S, Lania A, Rodolfo M, Peverelli E, Polentarutti N, Ferrero S, Bosari S, Beck-Peccoz P, Spada A: High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells. Oncogene 2008. IF: 6.582 65) Mantovani G, Lania A, Bondioni S, Peverelli E, Pedroni C, Ferrero S, Pellegrini C, Vicentini L, Arnoldi G, Bosari S, Beck-Peccoz P, Spada A: Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationships with cell proliferation. Exp Cell Res 2008. IF:3.777


66) Bondioni S, Angioni A, Corbetta S, Locatelli M, Ferrero S, Ferrante E, Mantovani G, Olgiati L, Beck-Peccoz P, Spada A, Lania A: Effect of 9-cis retinoid acid on dopamine D2 receptor expression in pituitary adenoma cells. Exp Biol Med 2008. I.F: 2.845 67) Cifola I, Spinelli R, Beltrame L, Peano C, Fasoli E, Ferrero S, Bosari S, Signorini S, Rocco F, Perego R, Proserpio V, Raimondo F, Mocarelli P, Battaglia C: Menome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol Cancer 2008. I.F: 3.620 68) Bosso N, Chinello C, Picozzi S, Gianazza E, Mainini V, Galbusera C, Raimondo F, Perego R, Casellato S, Rocco F, Ferrero S, Bosari S, Mocarelli P, Galli Kienle M, Magni F: Human urine biomarkers of renal cell carcinoma 15 fan15sa by ClinProt. Proteomics 2008. I.F: 5.735 69) Paggi S, Ferrero S, Braidotti P, De Rai P, Conte D, Basilisco G: Neuromuscolar alterations in the dilated ileum of an adult patient with segmental lymphangiectasia. Eur J Gastroenterol Hepatol 2008. I.F: 1.895 70) Perego R, Corizzato M, Brambilla P, Ferrero S, Bianchi C, Fasoli E, Signorini S, Torsello B, Invernizzi L, Bombelli S, Angeloni V, Pitto M, Battaglia C, Proserpio V, Magni F, Galasso G, Mocarelli P: Concentration and 15 fan15satellite status of plasma DNA for monitorino patients with renal carcinoma. Eur J Cancer 2008 . I.F : 4.459 71) Ciulla M, Montelatici E, Ferrero S, Braidotti P, Paliotti R, Annoni G, De Camilli E, Busca G, Chiappa L, Rebulla P, Magrini F, Lazzari L : Potential advantages of cell administration on the inflammatory responce compared to standard ACE inhibitor treatment in experimental myocardial infarction. Journal of Translational Medicine 2008. I.F: 3.300 72) Verruca E, Ronchi C.L., Ferranti E, Ferrari D.I., Bergamaschi S., Ferrero S, Zatelli M.C., Branca V, Spada A, Beck-Peccoz P, Lania A: Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secretine bronchial carcinoid tumour associated to a pituitari incidentaloma Pituitary 2010. I.F.: 2.021 73) Nosotti M, Tosi D, Palleschi A, Ferrero S, Rosso L: Transbronchial needle aspiration under direct endobronchial ultrasound guidance of PET-positive isolated mediastinal adenopathy in patients with previous malignancy. Surg Endosc 2009. I.F : 2.242


74) Sciola V, Massironi S, Conte D, Caprioli F, Ferrero S, Ciafardini C, Peracchi M, Bardella M T, Piodi L: Plasma chromogranin A in patients with inflammatory bowel disease. Inflamm Bowel Dis 2009. I.F: 4.705 75) Mantovani G, Bondioni S, Alberti L, Gilardini L, Invitti C, Corbetta S, Zappa M, Ferrero S, Lania A, Bosari S, Beck-Peccoz P, Spada A: PKA Regulatory Subunits in human adipose tissue: decreased R2B expression and activity in adipocytes from obese subjects. Diabetes 2009. I.F: 8.300 76) Ciulla M, Acquistapace G, Toffetti L, Paliotti R, Ferrero S, Magrini F, Braidotti P: Ki-67 cytoplamic staining: observations in normal cells from heart atrial appendages of healthy rats. Cell cycle 2009. I. F: 3.314 77) Peverelli E, Ermetici F, Filopanti M, Elli F, Ronchi C, Mantovani G, Ferrero S, Bosari S, Beck-Peccoz P, Lania A, Spada A : Analysis of genetic variants of phosphodiesterase 11° (PDE11A) in acromegalia patients. Eur J Endocrinol (2009). I.F.: 3.791 78) Chinello C, Gianazza E, Zoppis I, Mainini V, Galbusera C, Rocco F, Galasso G, Bosari S, Ferrero S, Perego R, Bianchi C, Signorini S, Brambilla P, Mocarelli P, Galli Kienle M, Magni F: Serum biomarkers of Renal Cell Carcinoma using a proteijn profiling approach based on ClinProt technique. Urology 2009 .I.F.: 2.242 79) Lania A, Ferrero S, Pivonello R, Mantovani G, Peverelli E, Di Sarno A, Beck Peccoz P, Spada A, Colao A.: Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation. J Clin Endocrinol Metab. 2010. I.F.: 6.325 80) Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini I, Bisceglia M, Beck-Peccoz P, Bosari S, Spada A: Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocrine-related cancer 2010. I.F.: 5.236 81) Locatelli M, Boiocchi L, Ferrero S, Martinelli Boneschi F, Zavanone M, Pesce S, Allavena P, Maria Gaini S, Bello L, Mantovani A: Human glioma tumors express high levels of the chemokine receptor CXCR1. Eur Cytokine Netw. 2010. I.F.: 2.984 82 ) Bianchi C, Bombelli S, Raimondo F, Torsello B, Angeloni V, Ferrero S, Di Stefano V, Chinello C, Cifola I, Invernizzi C, Brambilla P, Magni F, Pitto M, Zanetti G, Mocarelli P, Perego R.: Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3. Am J Pathol 2010. I.F.: 5.917


83) Del Gobbo A, Bimbatti M, Ferrero S: A case report of mesenteric mucinous cystoadenoma with review of the literature. BMC Gastroenterol 2010. I.F: 1.886 84) Elli L, Ciulla M, Busca G, Roncoroni L, Ferrero S, Bardella MT, Bonura A, Terrani C, Braidotti P: Beneficial effects of treatement with transglutaminase inhibitors cystamine on the severity of inflammation in a rat model of inflammatory bowel disease. Lab Invest 2011. I.F: 4.602 85) Nosotti M, Rosso L, Tosi D, Palleschi A, Mendogni P, Crotti S, Lissoni A, Ferrero S, Tarsia P, Santambrogio L: Late lung retransplantation using extracorporeal membrane oxygenation as a bridge: case report. Transplant Proc. 2011. I. F: 0.994 86) Cifola I, Bianchi C, Mangano E, Bombelli S, Frascati F, Fasoli E, Ferrero S, Di Stefano V, Zipeto M A, Magni F, Signorini S, Battaglia C, Perego R A: Renal cell carcinoma primary cultures mantein genomic and phenotypic profile of parental tumor tissues. BMC Cancer 2011. I.F: 2.736 87) Stolfi C, Rizzo A, Franze’ E, Rotondi A, Fantini MC, Sarra M, Caruso R, Monteleone I, Sileri P, Franceschilli L, Caprioli F, Ferrero S, MacDonalD T, Pallone F, Monteleone G: Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med 2011. I.F: 14.776 88) Basilisco G, Grande R, Ferrero S: Amebic colitis in Italy after Christmas. Dig Liver Disease 2012 . I.F: 2.805 89) Raimondo F, Morosi L, Chinello C, Perego R, Bianchi C, Albo G, Ferrero S, Rocco F, Magni F, Pitto M: Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples. Mol Biosyst 2012. I.F: 3.859 90) Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L, Dazzi D, Opocher G, Pelizzo M R, Beck-Peccoz P, Fugazzola L:: Comparison of Calcium and Pentagastrin Tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrin Metab 2012. I.F: 6.495 91) Nosotti M, Mendogni P, Rosso L, Tosi D, Palleschi A, Basciu M, Santambrogio L, Ferrero S: Alveolar adenoma of the lung: unusual diagnosis of a lesion positive on PET scan. A case report. J Cardiothorac Surg 2012. I.F: 1.187


92) Raimondo F, Salemi C, Chinello C, Fumagalli D, Morosi L, Rocco F, Ferrero S, Perego R, Bianchi C, Sarto C, Pitto M, Brambilla P, Magni F: Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE Mol Biosyst 2012. I.F: 3.859 93) Peverelli E, Mantovani G, Vitali E, Elli, FM, Olgiati L, Ferrero S, Laws EE, Della Mina P, Villa A , Beck-Peccoz, Spada A, Lania A.: Filamin-A is essential for Dopamine D2 Receptor expression and signaling in tumorous lactotrophs. J Clin Endocrin Metab 2012. I.F: 6.495 94) Spampatti M.P, Massironi S, Rossi R.E, Conte D, Sciola V, Ciafardini C, Ferrero S, Lodi L, Peracchi M: Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature. Eur J Gastroenterol Hepatol 2012. I.F: 1.598 95) Vaira V, Elli F, Forno I, Guarnieri V, Verdelli C, Ferrero S, Scillitani A, Vicentini L, Cetani F, Mantovani G, Spada A, Bosari S, Corbetta S.: Tre microRNA cluster C19MC is deregulated in parathyroid tumours. J Mol Endocrinol 2012. I.F. 3.628 96) Chae YC, Caino MC, Lisanti S, Ghosh JC, Dohi T, Danial NN, Villanueva J, Ferrero S, Vaira V, Santambrogio L, Bosari S, Languino LR, Herlyn M, Altieri DC.: Control of tumor bioenergetics and survival stress signaling by mitochondrial Hsp90s. Cancer Cell 2012. I.F: 26.566 97) Caprioli F, Bose’ F, Rossi RL, Petti L, Vigano’ C, Ciafardini C, Raeli L, Basilisco G, Ferrero S, Pagani M, Conte D, Altomare G, Monteleone G, Abrignani S, Reali E: Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy. Inflamm Bowel Dis 2013. I.F: 4,855 98) Gianazza E, Chinello C, Mainini V, Cazzaniga M, Squeo V, Albo G, Signorini S, Di Pierro S, Ferrero S, Nicolardi S, van der Burgt Y, Deelder AM, Magni F: Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors. J Proteomics 2012. I.F: 4,878 99) Elli L, Roncoroni L, Hils M, Pasternock R, Barisani D, Terrani C, Vaira V, Ferrero S, Bardella MT: Immunological effects of transglutaminase-treated gluten in coeliac disease. Hum Immunol 2012. I.F: 2.837 100) Valenza F, Rosso L, Gatti S, Coppola S, Froio S, Colombo J, Dossi R, Pizzocri M, Salice V, Nosotti M, Reggiani P, Tosi D, Palleschi A, Pappalettera M, Ferrero S, Perazzoli A, Costantini D, Scalamogna M, Rossi G, Colombo C, Santambrogio L, Gattinoni L:


Extracorporeal lung perfusion and ventilation to improve donor lung function and increase the number of organs available for transplantation. Transplant proc 2012. I.F.: 1.005 101) Rosso L, Parazzi V, Damarco F, Righi I, Santambrogio L, Rebulla P, Gatti S, Ferrero S, Nosotti M, Lazzari L: Pleural tissue repair with cord blood platelet gel. Blood Transfusion 2013. I.F: 2.099 102) Ciulla MM, Acqistapace G, Perrucci GL, Nicolini P, Toffetti L, Braidotti P, Ferrero S, Zucca I, Aquino D, Busca G, Magrini F: Immunohistochemical expression of oncological proliferation markers in the heart of rats during normal pregnancy. Biomarkers Med 2013. I.F: 2.630 103) Vaira V, Faversani A, Martin N , Garlik D, Ferrero S, Nosotti M, Kissil J, Bosari S, Altieri D: Regulation of lung cancer metastasis by Klf4-Numbel-like signaling. Cancer Res 2013. I.F: 7.856 104) Sala E, Ferrante E, Verrua E, Malchiodi E, Mantovani G, Filopanti M, Ferrero S, Pietrabissa A, Vanoli A, La Rosa S, Zatelli MC, Beck-Peccoz P, Verga U: Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype. Eur J Gastroenterol Hepatol 2013. I.F. 1.757 105) Locatelli M, Ferrero S, Martinelli Boneschi F, Boiocchi L, Zavanone M, Gaini S,M, Bello L, Valentino S, Barbati E, Nebuloni M, Mantovani A, Garlanda C: The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas. J Neuroimmunol 2013. I.F: 3.033 106) Caino M.C, Chan Chae Y, Vaira V, Ferrero S, Nosotti M, Martin N.M, Weeraratna A, O’Connell M, Jernigan D, Fatatis A, Languino L.R, Bosari S, Altieri D.C: Metabolic stress control of cytoskeletal dynamics and metastasis. J Clin Invest 2013. I.F: 13.069 107) Del Gobbo A, Fiori S, Gaudioso G, Nosotti M, Coggi G, Bosari S, Ferrero S: Pulmonary adenocarcinoma with massive lymphocytic infiltration: a case report with review of the literature of a rare histological entity with a peculiar biological behaviour. BMC Pulm Med 2013. I.F: 2.760 108) Fiori S, Del Gobbo A, Gaudioso G, Caccamo L, Massironi S, Cavalcoli F, Bosari S, Ferrero S.: Hepatic pseudocystic metastasis of well-differentiated ileal neuroendocrine tumor (NET): a case report with review of the literature. Diagn Pathol 2013. I.F: 1.850


109) Vaira V, Roncoroni L, Barisani D, Gaudioso G, Bosari S, Bulfamante G, Doneda L, Conte D, Tomba C, Bardella MT, Ferrero S, Locatelli M, Elli L: MicroRNA profiles in celiac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts. Clin Sci 2014. I.F: 4.859 110) Mian C, Perrino M, Colombo C, Cavedon E, Pennelli G, Ferrero S, De Leo S, Sarais C, Cacciatore C, Irene Manfredi G, Verga U, Iacobone M, De Pasquale L, Pelizzo MR, Vicentini L, Persani L, Fugazzola L.: Refining calcium test for the diagnosis of medullary thyroid cancer: cut-offs, procedures and safety. J Clin Endocrinol Metab 2014. I.F: 6.430 111) Del Gobbo A, Fiori S, Gaudioso G, Bonaparte E, Tabano S, Palleschi A, Bosari S, Ferrero S.: Syncronous pleural and peritoneal malignant mesothelioma: a case report and review of literature. Int J Clin Exp Pathol 2014. I.F: 2.040 112) Del Gobbo A, Vaira V, Guerini Rocco E, Palleschi A, Bulfamante G, Ricca D, Fiori S, Bosari S, Ferrero S: The oncofetal protein IMP3: A useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung. J Thorac Oncol 2014. I.F: 5.800 113) Massironi S, Rossi RE, Ferrero S, Cavalcoli F, Spampatti MP, Conte D, Corbetta S, Peracchi M: An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma: An unusual association and review of the literature. J Cancer Res Ther 2014. I.F: 0.761 114) Massari F, Ciccarese C, Porcaro AB, Ferrero S, Gazzano G, Artibani W, Modena A, Bria E, Sava T, Caliò A, Novara G, Ficarra V, Chilosi M, Martignoni G, Bosari S, Cheng L, Tortora G, Brunelli M.: Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma. Pathology 2014 . I.F: 2.620 115) Ferrero S, Vaira V, Del Gobbo A, Vicentini L, Bosari S, Beck-Peccoz P, Mantovani G, Spada A, Lania A: Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues. Histol Histopathol 2015. I.F.: 2.281 116) Del Gobbo A, Vaira V, Ferrari L, Patriarca C, Di Cristofori A, Ricca D, Caroli M, Rampini P, Bosari S, Ferrero S: The oncofetal protein IMP3: a novel grading tool and predictor of poor clinical outcome in human gliomas. Biomed Res Int 2015. I.F.: 2.706


117) Russo M.V, Faversani A, Gatti S, Ricca D, Del Gobbo A, Ferrero S, Palleschi A, Vaira V, Bosari S.: A new mouse avatar model of non-small cell lung cancer. Front Oncol 2015. 118) Cirello V, Rizzo R, Crippa M, Campi I, Bortolotti D, Bolzani S, Colombo C, Vannucchi G, Maffini MA, de Liso F, Ferrero S, Finelli P, Fugazzola L.: Fetal cell microchimerism: a protective role in autoimmune thyroid diseases. Eur J Endocrinol 2015. I.F.: 3.686 119) Palmieri S, Eller-Vainicher C, Cairoli E, Morelli V, Zhukouskaya VV, Verga U, Filopanti M, Vicentini L, Ferrero S, Spada A, Chiodini I.: Hypercalciuria may persist after successful parathyroid surgery and it is associated with parathyroid hyperplasia. J Clin Endocrinol Metab 2015. I.F.: 6.310 120) Di Cristofori A, Ferrero S, Bertolini I, Gaudioso G, Russo MV, Berno V, Vanini M, Locatelli M, Zavanone M, Rampini P, Vaccari T, Caroli M, Vaira V.: The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma. Oncotarget 2015. I.F.: 6.630 121) Forno I, Ferrero S, Russo MV, Gazzano G, Giangiobbe S, Montanari E, Del Nero A, Rocco B, Albo G, Languino L, Altieri DC, Vaira V, Bosari S.: Deregulation of MiR-34b/S0x2 predicts prostate cancer progression. PLoS One .2015. I.F.: 3.534 122) Del Gobbo A, Pellegrinelli A, Gaudioso G, Castellani M, Zito Marino F, Franco R, Palleschi A, Nosotti M, Bosari S, Vaira V, Ferrero S. : Analysis of NSCLC tumor heterogeneity, proliferative and 18F-FDG PET indexes reveals Ki67 prognostic role in adenocarcinomas. Histopathology 2016. I.F.: 3.453 123) Elli L, Zini E, Tomba C, Bardella MT, Bosari S, Conte D, Runza L, Roncoroni L, Ferrero S.: Histological evaluation of duodenal biopsies from coeliac patients: the need for different grading criteria during follow-up. BMC Gastroenterol 2015. I.F: 2.370 124) Marino FZ, Liguori G, Aquino G, La Mantia E, Bosari S, Ferrero S, Rosso L, Gaudioso G, De Rosa N, Scrima M,Martucci N, La Rocca A, Normanno N, Morabito A, Rocco G, Botti G, Franco R.: Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma. PloS One 2015. I.F:3.534 125) Fusco N, Runza L, Elli L, Ferrero S.: Approaching the histodynamics of celiac disease in modern times: the need of going beyond the dogmas. Dig Liver Dis 2016. I.F.: 2.963


126) Fusco N, Guerini-Rocco E, Del Gobbo A, Franco R, Zito-Marino F, Vaira V, Bulfamante G, Ercoli G, Nosotti M, Palleschi A, Bosari S, Ferrero S.: The contrasting role of p16 Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors: a comprehensive analysis with clinicopathologic and molecular correlations. PloS One 2015. I.F.: 3.534 127) Cistermino A, Asa’ad F, Fusco N, Ferrero S, Rasperini G.: Role of multidisciplinary approch in a case of Langerhans cell histiocytosis with initial periodontol manifestations. Int J Clin Exp Pathol 2015. I.F.: 1.891 128) Giammattei L, Mantovani G, Carrabba G, Ferrero S, Di Cristofori A, Verrua E, Guastella C, Pignataro L, Rampini P, Minichello M, Locatelli M.: Pituitary apolexy: considerations on a single center experience and review of the literature. J Endocrinol Invest 2016. I.F.: 1.448 129) Fusco N, Sciarra A, Guerini-Rocco E, Marchiò C, Vignani F, Colombo P, Ferrero S: Rediscovering secondary tumors of the prostate in the molecular era. Adv Anat Pathol 2016. I.F.: 3.229 130) Protti A, Maraffi T, Milesi M, Votta E, Santini A, Pugni P, Andreis D, Nicosia F, Zannin E, Gatti S, Vaira V, Ferrero S, Gattinoni L.: Role of Strain rate in the pathogenesis of ventilator-induced lung edema. Crit Care Med 2016. I.F.: 6.312 131) Protti A, Properzi P, Magnoni S, Santini A, Langer T, Guenzani S, Ferrero S, Bassani G, Stocchetti N, Gattinoni L. : Skeletal muscle lactate overproduction during metformin intoxication: an animal study with reverse microdialysis. Toxicol Lett 2016. I.F.: 3.262 132) Lavezzi AM, Ferrero S, Roncati L, Matturri, L, Pusiol T.: Impaired orexin receptor expression in the kolliker-fuse nucleus in sudden infant death syndrome: possible involvment of this nucleus in arousal pathophysiology. Neurol Res 2016. I.F.: 1.439 133) Del Gobbo A, Peverelli E, Treppiedi D, Lania A, Mantovani G, Ferrero S.: Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues: a systematic review. Exp Cell Res 2016. I.F.: 3.378 134) Lavezzi AM, Ferrero S, Matturri L, Pusiol T.: Developmental neuropathology of brainstem respiratory centers in unexplained stillbirth: what’s the meaning?. Int J Dev Neurosci 2016. I.F.: 2.380


135) Del Gobbo A, Vingiani A, Masci E, Faillace G, Barbaro S, Bonaparte E, Ferrero S.: Pulmonary squamous cell carcinoma with lepidic growth pattern: new insights into lung cancer classification. Int J Clin Exp Pathol 2016. I.F.: 1.891 136) Peverelli E, Giardino E, Treppiedi D, Locatelli M, Vaira V, Ferrero S, Bosari S, Lania AG, Spada A, Mantovani G.: Dopamine receptor type 2 (DRD2) inhibots migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation. Cancer Lett 2016. I.F.: 5.992 137) Caino MC, Seo, J, Aguinaldo A, Wait E, Bryant K, Kossenkov A, Hayden J, Vaira V, Morotti A, Ferrero S, Bosari S, Gabrilovich D, Languino L, Cohen A, Altieri C.: A neuronal network of mitochondrial dynamics regulates metastasis. Nat Commun 2016. I.F.: 11.329 138) Elli L, Villalta D, Roncoroni L, Barisani D, Ferrero S, Pellegrini N, Bardella MT, Valiante F, Tomba C, Carroccio A, Bellini M, Soncini M, Cannizzaro R, Leandro G.: Nomenclature and diagnosis of gluten-related disorders: a position statement by the italian association of hospital gastroenterologists and endoscopists (AIGO). Dig Liver Dis 2016. I.F.: 2.719 139) Mingione A, Verdelli C, Ferrero S, Vaira V, Guarnieri V, Scillitani A, Vicentini L, Balza G, Beretta E, Terranegra A, Vezzoli G, Soldati L, Corbetta S.: Filamin A is reduced and contributes to CASR sensitivity in human parathyroid tumors. J Mol Endocrinol 2016. I.F.: 2.947 140) Cirello V, Vaira V, Grassi ES, Vezzoli V, Ricca D, Colombo C, Bosari S, Vicentini L, Persani L, Ferrero S, Fugazzola L.: Multicellular spheroids from normal and neoplastic thyroid tissues as suitable model to test the effects of multikinase inhibitors. Oncotarget 2016. I.F.: 5.008 141) Faversani A, Amatori S, Augello C, Colombo F, Porretti L, Fanelli M, Ferrero S, Palleschi A, Pelicci PG, Belloni E, Ercoli G, Degrassi A, Baccarin M, Altieri DC, Vaira V, Bosari S.: miR-494-3p is a novel tumor driver of lung carcinogenesis. Oncotarget 2016. I.F.: 5.008 142) Fusco N, Guerini-Rocco E, Augello C, Terrasi A, Ercoli G, Fumagalli C, Vacirca D, Braidotti P, Parafioriti A, Jaconi M, Runza L, Ananthanarayanan V, Pagni F, Bosari S, Barberis M, Ferrero S.: Recurrent Nab2-Stat6 gene fusions and estrogen receptor alpha expression in pulmonary adenofibromas. Histopathology 2017. I.F.: 3.425


143) Del Gobbo A, Ferrero S: Immunohistochemical markers as predictors of histopathologic response and prognosis in rectal cancer treated with preoperative adjuvant therapy: state of the art. Gastroenterology Research and Practice 2017. I.F.: 1.742 144) Peverelli E, Giardino E, Treppiedi D, Meregalli M, Belicchi M, Vaira V, Corbetta S, Verdelli C, Verrua E, Serban AL, Locatelli M, Carrabba G, Gaudenzi G, Malchiodi E, Cassinelli L, Lania AG, Ferrero S, Bosari S, Vitale G, Torrente Y, Spada A, Mantovani G.: Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from non functioning pituitary tumors. Int J Cancer 2017. IF.: 5,531 145) Cirello V, Gaudenzi G, Grassi ES, Colombo C, Vicentini L, Ferrero S, Persani L, Vitale G, Fugazzola L.: Tumor and normal thyroid spheroids: from tissue to zebrafish Minerva Endocrinol 2017. IF.: 1,118 146) Di Sabatino A, Vanoli A, Furlan D, Giuffrida P, Klersy C, Grillo F, Fiocca R, Mescoli C, Rugge M, Nesi G, Fociani P, Sampietro G, Ardizzone S, Luinetti O, Calabrò A, Tonelli F, Volta U, Santini D, Caio G, Elli L, Ferrero S, Latella G, Ciardi A, Solina G, Rizzo A, Ciacci C, D’Armiento FP, Salemme M, Villanacci V, Cannizzaro R, Canzonieri V, Reggiani Bonetti L, Biancone L, Monteleone G, Orlandi A, Santeusanio G, Macciomei MC, D’Incà R, Perfetti V, Sandri G, Silano M, Florena AM, Giannone AG, Papi C, Coppola L, Usai P, Maccioni A, Astegiano M, Migliora P, Manca R, Martino M, Trapani D, Cerutti R, Alberizzi P, Riboni R, Sessa F, Paulli M, Solcia E, Corazza GR. P301 Non-familial small bowel carcinomas in Crohn’s disease: clinico-pathological, molecular and prognostic features. J Crohns Colitis 2017. IF.: 6,585 147) Massironi S, Del Gobbo A, Cavalcoli F, Fiori S, Conte D, Pellegrinelli A, Milione M, Ferrero S.: IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence. Endocrine 2017. IF.: 3,279 148) Colombo C, Muzza M, Proverbio MC, Ercoli G, Perrino M, Cirello V, Vicentini L, Ferrero S, Fugazzola L.: Segregation and expression analyses of HABP2: insights from a large series of familiar medullary thyroid cancers and literature review. Clin Endocrinol: 2017. IF.: 3,487 149) Nesa F, Poggi L, Ferrero S, Del Gobbo A.: Thyroid follicular hyperplasia associated with massive extracellular mucin deposition. Int J Surg Pathol. 2017. I.F. 0.782 150) Rosso L, Ferrero S, Mendogni P, Bonaparte E, Carrinola R, Palleschi A, Righi I, Montoli M, Demarco F, Tosi D: Ten-year experience with endobronchial ultrasound-guided


transbronchial needle aspiration: single center results in mediastinal diagnostic and staging. Journal of Thoracic Disease 2017. I.F.: 1,649 151) Renda A, Vergani C, Venturi M, Ferrero S, Del Gobbo A: Diffuse melanosis in pericolic lymph nodes associated with laxative abuse and colorectal cancer. Int J Surg Pathol 2017. I.F.: 0,830 152) Lavezzi AM, Ferrero S, Roncati L, Piscioli F, Matturri L, Pusiol T.: Nicotinic receptor abnormalities in the cerebellar cortex of sudden unexplained fetal and infant death victims-possible correlation with maternal smoking. ASN Neuro 2017. I.F. 3,030 153) Guanziroli E, Coggi A, Venegoni L, Fanoni D, Ercoli G, Boggio F, Veraldi S, Berti E, Gianotti R, Ferrero S, Del Gobbo A.: Cutaneous metastases of internal malignancies: an experience from a single institution. Eur J Dermatol 2017. I.F. 2.243 154) Verdelli C, Avagliano L, Guarnieri V, Cetani F, Ferrero S, Vicentini L, Beretta E, Scillitani A, Creo P, Bulfamante G, Vaira V, Corbetta S.: Expression, function and regulation of the embryonic transcription factor TBX1 in parathyroid tumors. Lab Invest 2017. I.F. 4.857 155) Lavezzi AM, Ferrero S, Piscioli F, Matturri L.: New insights into the pathophysiological expression of brain-derived neurotrophic factor (BDNF) in cerebellar cortex of sudden fetal and infant death victims. Int J Mol Sci 2017. I.F. 3.226 156) Pesenti C, Paganini L, Fontana L, Veniani E, Runza L, Ferrero S, Bosari S, Menghi M, Marfia G, Caroli M, Silipigni R, Guarneri S, Tabano S, Miozzo M.: Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codelection, and IDH1, IDH2, and TERT mutation status. Oncotarget 2017. I.F. 5.168 157) Peverelli E, Catalano R, Giardino E, Treppiedi D, Morelli V, Ronchi CL, Vaczlavik A, Fusco N, Ferrero S, Bertherat J, Beuschlein F, Chiodini I, Arosio M, Spada A, Mantovani G.: Cofilin is a cAMP effector in mediating actin cytosckeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells. Cancer Letters 2017. I.F. 6.375 158) Vitali E, Boemi I, Rosso L, Cambiaghi V, Novellis P, Mantovani G, Spada A, Alloisio M, Veronesi G, Ferrero S, Lania A.: FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression. Oncotarget 2017. I.F. 5.168


159) Lattuada D, Alfonsi G, Roncati L, Pusiol T, Bulfoni A, Ferrero S, Lavezzi AM.: Mitochondrial DNA content: A new biomarker for sudden intrauterine unexplained death syndrome (SIUDS). Mitochondrion 2017. I.F. 3.704 160) Rostami K, Marsch M, Johnson M, Mohaghegh H, Heali C, Holmes G, Ensari A, Aldulaimi D, Bancel B, Bassoti G, Bateman A, Becheanu G, Bozzola A, Carroccio A, Catassi C, Ciacci C, Ciobanu A, Danciu M, Derakhshan M, Elli L, Ferrero S, Fiorentino M, Fiorino M, Ganji A, Ghaffarzadehgan K, Going J, Ishaq S, Mandolesi A, Mathews S, Maxim R, Mulder C, Neefjes-Borst A, Robert M, Russo I, Rostami-Nejad M, Sidoni A, Sotoudeh M, Villanacci V, Volta U, Zali M, Srivastava A.: ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation. Gut 2017. I.F. 16.658 161) Moriggi M, Pasrorelli L, Torretta E, Tontini GE, Capitanio D, Ferrero S, Vecchi M, Gelfi C: Contribution of extracellular matrix and signal mechanotransduction to epithelial cell damage in inflammatory bowel disease patients: aproteomic study. Proteomics 2017. I.F. 4.041

Milano; 2017

STEFANO FERRERO BOGETTO VIA ORTI MILANO - unimi.it · FO R M A T O EU R O P EO P E R I L C U R RI C...

Documents

Transcript of STEFANO FERRERO BOGETTO VIA ORTI MILANO - unimi.it · FO R M A T O EU R O P EO P E R I L C U R RI C...